Tzen KY - Search Results

1

Characterization of neuroblastic tumors using 18F-FDOPA PET.

Lu MY, Liu YL, Chang HH, Jou ST, Yang YL, Lin KH, Lin DT, Lee YL, Lee H, Wu PY, Luo TY, Shen LH, Huang SF, Liao YF, Hsu WM, Tzen KY; National Taiwan University Neuroblastoma Study Group. Lu MY, et al. Among authors: tzen ky. J Nucl Med. 2013 Jan;54(1):42-9. doi: 10.2967/jnumed.112.102772. Epub 2012 Dec 4. J Nucl Med. 2013. PMID: 23213196 Free article.

2

Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.

Liu YL, Lu MY, Chang HH, Lu CC, Lin DT, Jou ST, Yang YL, Lee YL, Huang SF, Jeng YM, Lee H, Miser JS, Lin KH, Liao YF, Hsu WM, Tzen KY. Liu YL, et al. Among authors: tzen ky. Oncotarget. 2016 Apr 5;7(14):18774-86. doi: 10.18632/oncotarget.7933. Oncotarget. 2016. PMID: 26959748 Free PMC article.

3

Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.

Liu CJ, Lu MY, Liu YL, Ko CL, Ko KY, Tzen KY, Chang HH, Yang YL, Jou ST, Hsu WM, Yen RF. Liu CJ, et al. Among authors: tzen ky. Clin Nucl Med. 2017 Mar;42(3):e142-e148. doi: 10.1097/RLU.0000000000001529. Clin Nucl Med. 2017. PMID: 28072621

4

Impact of residual (18)F-fluoride in (18)F-FDOPA for the diagnosis of neuroblastoma.

Huang YY, Tzen KY, Liu YL, Chiu CH, Tsai CL, Wen HP, Tang KH, Liu CC, Shiue CY. Huang YY, et al. Among authors: tzen ky. Ann Nucl Med. 2015 Jul;29(6):489-98. doi: 10.1007/s12149-015-0970-x. Epub 2015 Apr 8. Ann Nucl Med. 2015. PMID: 25851249

5

Search of Unknown Fever Focus Using PET in Critically Ill Children With Complicated Underlying Diseases.

Chang L, Cheng MF, Jou ST, Ko CL, Huang JY, Tzen KY, Yen RF. Chang L, et al. Among authors: tzen ky. Pediatr Crit Care Med. 2016 Feb;17(2):e58-65. doi: 10.1097/PCC.0000000000000601. Pediatr Crit Care Med. 2016. PMID: 26649939

6

A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.

Chang HH, Liu YL, Lu MY, Jou ST, Yang YL, Lin DT, Lin KH, Tzen KY, Yen RF, Lu CC, Liu CJ, Peng SS, Jeng YM, Huang SF, Lee H, Juan HF, Huang MC, Liao YF, Lee YL, Hsu WM. Chang HH, et al. Among authors: tzen ky. Oncotarget. 2017 Jan 17;8(3):4360-4372. doi: 10.18632/oncotarget.13874. Oncotarget. 2017. PMID: 27966455 Free PMC article.

7

Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.

Yen RF, Hong RL, Tzen KY, Pan MH, Chen TH. Yen RF, et al. Among authors: tzen ky. J Nucl Med. 2005 May;46(5):770-4. J Nucl Med. 2005. PMID: 15872349 Free article.

8

Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1.

Wu YW, Kao HL, Chen MF, Lee BC, Tseng WY, Jeng JS, Tzen KY, Yen RF, Huang PJ, Yang WS. Wu YW, et al. Among authors: tzen ky. J Nucl Med. 2007 Feb;48(2):227-33. J Nucl Med. 2007. PMID: 17268019 Free article.

9

Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis.

Cheng MF, Wu YW, Liu KL, Yen RF, Wu YM, Hsu C, Chang YT, Tzen KY, Wang HP. Cheng MF, et al. Among authors: tzen ky. Nucl Med Commun. 2011 Apr;32(4):252-9. doi: 10.1097/MNM.0b013e32834368bf. Nucl Med Commun. 2011. PMID: 21326124

10

Usefulness of PET/CT for the differentiation and characterization of periampullary lesions.

Cheng MF, Wang HP, Tien YW, Liu KL, Yen RF, Tzen KY, Wu YW. Cheng MF, et al. Among authors: tzen ky. Clin Nucl Med. 2013 Sep;38(9):703-8. doi: 10.1097/RLU.0b013e31829b266a. Clin Nucl Med. 2013. PMID: 23816944 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters